查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1396953

基因检测市场：按类型、技术和应用划分：2023-2032 年全球机会分析和产业预测

Genetic Testing Market By Type, By Technology, By Application : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 428 Pages | 商品交期: 2-3个工作天内

价格

2022年基因检测市值为155.3353亿美元，预计2032年将达到408.7242亿美元，2023年至2032年复合年增长率为10.2%。

基因检测是对 DNA 的研究，旨在识别与各种遗传性疾病相关的基因突变。基因检测有许多不同类型，包括细胞遗传学检测、生化检测、分子检测和染色体分析，以研究染色体、基因和蛋白质的变化。基因检测结果有助于确认和诊断疑似遗传疾病，以及确定遗传疾病的发病和遗传的可能性。

基因检测市场的成长是由基因检测数量的增加和疾病诊断技术进步的增加所推动的。此外，基因组研究的不断进步使人们更了解疾病和性状的遗传基础。这扩大了临床和非临床目的基因检测的范围。此外，人们对遗传疾病及其对健康影响的认识不断提高，导致对基因检测的需求增加。遗传疾病的早期发现对于及时介入和治疗至关重要。因此，这一因素预计将推动市场成长。此外，美国等新兴国家的基因检测数量不断增加预计将在预测期内推动市场成长。例如，根据美国国家医学图书馆的数据，截至 2022 年 11 月，美国进行的基因检测总数为 129,624 次。此外，据同一消息来源称，2022 年全球进行的基因检测数量据报道为 197,779 次。

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 遗传性疾病增加
      • 癌症盛行率增加
      • 基因检测数量增加
    • 抑制因素
      • 基因检测费用高
    • 机会
      • 更多采用关键战略。

第四章 基因检测市场：依类型

  • 概述
  • 预测性和预测性测试
  • 承运人检查
  • 产前/新生儿检测
  • 诊断测试
  • 药物基因组测试
  • 其他的

第五章 基因检测市场：依技术分类

  • 概述
  • 细胞遗传学检测
  • 生物化学检验
  • 分子检测

第六章 基因检测市场：依应用分类

  • 概述
  • 癌症诊断
  • 遗传疾病诊断
  • 其他的

第七章 基因检测市场：依地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第八章 竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2022年主要企业定位

第九章 公司简介

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Myriad Genetics, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen NV
  • CSL Limited
  • Luminex Corporation
Product Code: A04878

The Genetic Testing Market was valued for $15,533.53 million in 2022 and is estimated to reach $40,872.42 million by 2032, exhibiting a CAGR of 10.2% from 2023 to 2032. Genetic testing is the study of DNA that identifies gene mutation associated with a variety of genetic disorders. There are various types of genetic testing and several methods such as cytogenetic testing, biochemical testing, molecular testing, and chromosome analysis used to determine changes in a person's chromosomes, genes, or proteins. The results of a genetic tests confirm or diagnose a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder.

The genetic testing market growth is driven by rise in number of genetic tests and increase in use of technological advancements for diagnosis of diseases. In addition, ongoing advancements in genomic research have led to a better understanding of the genetic basis of diseases and traits. This has expanded the scope of genetic testing for both clinical and non-clinical purposes. Moreover, the increasing awareness of genetic disorders and their impact on health has led to greater demand for genetic testing. Early detection of genetic diseases is crucial for timely intervention and treatment. Thus, this factor is anticipated to boost the growth of market. Moreover, rise in number of genetic testing in developed countries such as the U.S. is expected to fuel the growth of market in the forecast period. For instance, according to National Library of Medicine, as of November 2022, a total of number of genetic tests performed in the U.S. are 129,624. In addition, as per the same source, it was reported that 197,779 genetic tests were performed globally in 2022.

In addition, genetic testing has become integral in the field of oncology. It helps in identifying genetic mutations that drive cancer and guides the selection of targeted therapies. Thus, rise in number of populations suffering from cancer and technological advancement for diagnosis of cancer are expected to boost the growth of market. Moreover, genetic testing is becoming more common in prenatal and neonatal care, aiding in the early detection of genetic abnormalities. Prenatal and neonatal screening allows for the early detection of genetic disorders and congenital conditions. Identifying these conditions in the earliest stages of development enables healthcare providers to take proactive measures to manage and treat them effectively. Thus, this factor is anticipated to fuel the growth of market.

The genetic testing market is segmented into type, technology, application, and region. By type, the market is categorized into predictive & pre-symptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others. Based on technology, it is divided into cytogenetic testing, biochemical testing, and molecular testing. Molecular testing is further classified into DNA sequencing and others. As per application, it is segmented into cancer diagnosis, genetic disease diagnosis, and others.

Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Major key players that operate in the global genetic testing market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Eurofins Scientific, Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., and CSL Ltd. Key players operating in the market have adopted product approval, product launch, acquisition and agreement as their key strategies to expand their genetic testing market share.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the genetic testing market analysis from 2022 to 2032 to identify the prevailing genetic testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the genetic testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global genetic testing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Product Benchmarking / Product specification and applications
  • Upcoming/New Entrant by Regions
  • New Product Development/ Product Matrix of Key Players
  • Patient/epidemiology data at country, region, global level
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Market share analysis of players at global/region/country level

Key Market Segments

By Type

  • Carrier Testing
  • Prenatal and Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Others
  • Predictive and Presymptomatic Testing

By Technology

  • Cytogenetic testing
  • Biochemical testing
  • Molecular testing

By Application

  • Cancer diagnosis
  • Genetic disease diagnosis
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Bio-Rad Laboratories, Inc.
    • Myriad Genetics, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Illumina, Inc.
    • Qiagen N.V
    • Luminex Corporation
    • Abbott Laboratories
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc.
    • CSL Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of genetic diseases
      • 3.4.1.2. Increase in prevalence of cancer
      • 3.4.1.3. Rise in the number of genetic testing.
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of genetic testing
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in number of adoptions of key strategies.

CHAPTER 4: GENETIC TESTING MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Predictive and Presymptomatic Testing
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Carrier Testing
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Prenatal and Newborn Testing
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Diagnostic Testing
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Pharmacogenomic Testing
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country
  • 4.7. Others
    • 4.7.1. Key market trends, growth factors and opportunities
    • 4.7.2. Market size and forecast, by region
    • 4.7.3. Market share analysis by country

CHAPTER 5: GENETIC TESTING MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Cytogenetic testing
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Biochemical testing
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Molecular testing
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: GENETIC TESTING MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Cancer diagnosis
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Genetic disease diagnosis
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: GENETIC TESTING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Technology
    • 7.2.4. Market size and forecast, by Application
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Technology
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Technology
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Technology
      • 7.2.5.3.3. Market size and forecast, by Application
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Technology
    • 7.3.4. Market size and forecast, by Application
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Technology
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Technology
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Technology
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Technology
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Technology
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Technology
      • 7.3.5.6.3. Market size and forecast, by Application
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Technology
    • 7.4.4. Market size and forecast, by Application
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Technology
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Technology
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Technology
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Technology
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Technology
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type
      • 7.4.5.6.2. Market size and forecast, by Technology
      • 7.4.5.6.3. Market size and forecast, by Application
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Technology
    • 7.5.4. Market size and forecast, by Application
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Technology
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Technology
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Technology
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Technology
      • 7.5.5.4.3. Market size and forecast, by Application

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Abbott Laboratories
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Bio-Rad Laboratories, Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Myriad Genetics, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Danaher Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. F. Hoffmann-La Roche Ltd.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Illumina, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Thermo Fisher Scientific, Inc.
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. Qiagen N.V
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. CSL Limited
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Luminex Corporation
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. GENETIC TESTING MARKET FOR PREDICTIVE AND PRESYMPTOMATIC TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GENETIC TESTING MARKET FOR CARRIER TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GENETIC TESTING MARKET FOR PRENATAL AND NEWBORN TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GENETIC TESTING MARKET FOR DIAGNOSTIC TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. GENETIC TESTING MARKET FOR PHARMACOGENOMIC TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GENETIC TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 09. GENETIC TESTING MARKET FOR CYTOGENETIC TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GENETIC TESTING MARKET FOR BIOCHEMICAL TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 13. GENETIC TESTING MARKET FOR CANCER DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GENETIC TESTING MARKET FOR GENETIC DISEASE DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GENETIC TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GENETIC TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 23. U.S. GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. CANADA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. CANADA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 26. CANADA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. UK GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. UK GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 42. UK GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. ITALY GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. ITALY GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 45. ITALY GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 48. SPAIN GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. CHINA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. CHINA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 61. CHINA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. INDIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. INDIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 64. INDIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA GENETIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 78. BRAZIL GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 80. BRAZIL GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA GENETIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA GENETIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA GENETIC TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 90. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 91. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 92. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 93. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 94. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
  • TABLE 95. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • TABLE 96. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
  • TABLE 97. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
  • TABLE 98. MYRIAD GENETICS, INC.: KEY EXECUTIVES
  • TABLE 99. MYRIAD GENETICS, INC.: COMPANY SNAPSHOT
  • TABLE 100. MYRIAD GENETICS, INC.: SERVICE SEGMENTS
  • TABLE 101. MYRIAD GENETICS, INC.: PRODUCT PORTFOLIO
  • TABLE 102. MYRIAD GENETICS, INC.: KEY STRATERGIES
  • TABLE 103. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 104. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 105. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 106. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 107. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 108. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 109. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
  • TABLE 110. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 111. ILLUMINA, INC.: KEY EXECUTIVES
  • TABLE 112. ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 113. ILLUMINA, INC.: PRODUCT SEGMENTS
  • TABLE 114. ILLUMINA, INC.: PRODUCT PORTFOLIO
  • TABLE 115. ILLUMINA, INC.: KEY STRATERGIES
  • TABLE 116. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 117. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 118. THERMO FISHER SCIENTIFIC, INC.: PRODUCT SEGMENTS
  • TABLE 119. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 120. QIAGEN N.V: KEY EXECUTIVES
  • TABLE 121. QIAGEN N.V: COMPANY SNAPSHOT
  • TABLE 122. QIAGEN N.V: PRODUCT SEGMENTS
  • TABLE 123. QIAGEN N.V: PRODUCT PORTFOLIO
  • TABLE 124. CSL LIMITED: KEY EXECUTIVES
  • TABLE 125. CSL LIMITED: COMPANY SNAPSHOT
  • TABLE 126. CSL LIMITED: PRODUCT SEGMENTS
  • TABLE 127. CSL LIMITED: PRODUCT PORTFOLIO
  • TABLE 128. LUMINEX CORPORATION: KEY EXECUTIVES
  • TABLE 129. LUMINEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 130. LUMINEX CORPORATION: PRODUCT SEGMENTS
  • TABLE 131. LUMINEX CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. GENETIC TESTING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF GENETIC TESTING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN GENETIC TESTING MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN GENETIC TESTING MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL GENETIC TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. GENETIC TESTING MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR PREDICTIVE AND PRESYMPTOMATIC TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR CARRIER TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR PRENATAL AND NEWBORN TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR DIAGNOSTIC TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR PHARMACOGENOMIC TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. GENETIC TESTING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR CYTOGENETIC TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR BIOCHEMICAL TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. GENETIC TESTING MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR CANCER DIAGNOSIS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR GENETIC DISEASE DIAGNOSIS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF GENETIC TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. GENETIC TESTING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 27. U.S. GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. CANADA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. MEXICO GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. GERMANY GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. FRANCE GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. UK GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. ITALY GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SPAIN GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. REST OF EUROPE GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. JAPAN GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. CHINA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. INDIA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. AUSTRALIA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SOUTH KOREA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF ASIA-PACIFIC GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. BRAZIL GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SAUDI ARABIA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF LAMEA GENETIC TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: GENETIC TESTING MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022
  • FIGURE 50. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. MYRIAD GENETICS, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 57. MYRIAD GENETICS, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 58. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 61. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 64. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 66. THERMO FISHER SCIENTIFIC, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 67. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 68. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 69. QIAGEN N.V: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 70. QIAGEN N.V: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 71. CSL LIMITED: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 72. CSL LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 73. CSL LIMITED: REVENUE SHARE BY REGION, 2022 (%)